Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 handwiki Dean Liu -- 2096 2022-10-26 01:44:44

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
HandWiki. Ciclosporin. Encyclopedia. Available online: https://encyclopedia.pub/entry/31630 (accessed on 24 September 2026).
HandWiki. Ciclosporin. Encyclopedia. Available at: https://encyclopedia.pub/entry/31630. Accessed September 24, 2026.
HandWiki. "Ciclosporin" Encyclopedia, https://encyclopedia.pub/entry/31630 (accessed September 24, 2026).
HandWiki. (2022, October 27). Ciclosporin. In Encyclopedia. https://encyclopedia.pub/entry/31630
HandWiki. "Ciclosporin." Encyclopedia. Web. 27 October, 2022.
Ciclosporin
Edit

Ciclosporin, also spelled cyclosporine and cyclosporin, is a calcineurin inhibitor, used as an immunosuppressant medication. It is a natural product. It is taken orally or intravenously for rheumatoid arthritis, psoriasis, Crohn's disease, nephrotic syndrome, and in organ transplants to prevent rejection. It is also used as eye drops for keratoconjunctivitis sicca (dry eyes). Common side effects include high blood pressure, headache, kidney problems, increased hair growth, and vomiting. Other severe side effects include an increased risk of infection, liver problems, and an increased risk of lymphoma. Blood levels of the medication should be checked to decrease the risk of side effects. Use during pregnancy may result in preterm birth; however, ciclosporin does not appear to cause birth defects. Ciclosporin is believed to work by decreasing the function of lymphocytes. It does this by forming a complex with cyclophilin to block the phosphatase activity of calcineurin, which in turn decreases the production of inflammatory cytokines by T-lymphocytes. Ciclosporin was isolated in 1971 from the fungus Tolypocladium inflatum and came into medical use in 1983. It is on the World Health Organization's List of Essential Medicines. In 2019, it was the 195th most commonly prescribed medication in the United States, with more than 2 million prescriptions that year. It is available as a generic medication.

cyclophilin inflammatory cytokines cyclosporin

References

  1. "Sandimmune- cyclosporine capsule, liquid filled Sandimmune- cyclosporine injection Sandimmune- cyclosporine solution". http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e5926a7-1de0-4b54-a5c0-286b6200ff82. 
  2. "Neoral- cyclosporine capsule, liquid filled Neoral- cyclosporine solution". http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=94461af3-11f1-4670-95d4-2965b9538ae3. 
  3. "Lokales Cyclosporin A bei Nummuli nach Keratoconjunctivitis epidemica Eine Pilotstudie - Springer". Der Ophthalmologe 97 (11): 764–768. 2000. doi:10.1007/s003470070025. PMID 11130165.  https://dx.doi.org/10.1007%2Fs003470070025
  4. "Restasis- cyclosporine emulsion". http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e24af2b-bc1c-4849-94f2-6df950cdca89. 
  5. Lee, SS; Tan, AW; Giam, YC (May 2004). "Cyclosporin in the Treatment of Severe Atopic Dermatitis: A Retrospective Study". Annals of the Academy of Medicine, Singapore 33 (3): 311–3. PMID 15175770. http://www.annals.edu.sg/pdf200405/V33N3p311.pdf. 
  6. Dijkmans, BA; van Rijthoven, AW; Goei Thè, HS; Boers, M; Cats, A (August 1992). "Cyclosporine in rheumatoid arthritis". Seminars in Arthritis and Rheumatism 22 (1): 30–36. doi:10.1016/0049-0172(92)90046-g. PMID 1411580. https://www.sciencedirect.com/science/article/abs/pii/004901729290046G. Retrieved 31 May 2022. 
  7. "Cyclosporine in severe ulcerative colitis refractory to steroid therapy". The New England Journal of Medicine 330 (26): 1841–5. June 1994. doi:10.1056/NEJM199406303302601. PMID 8196726.  https://dx.doi.org/10.1056%2FNEJM199406303302601
  8. "Calcineurin inhibitor nephrotoxicity". Clinical Journal of the American Society of Nephrology 4 (2): 481–508. February 2009. doi:10.2215/CJN.04800908. PMID 19218475. http://cjasn.asnjournals.org/content/4/2/481.full.pdf. 
  9. "Effect of cyclosporine on blood pressure". Cochrane Database of Systematic Reviews (1): CD007893. January 2010. doi:10.1002/14651858.CD007893.pub2. PMID 20091657.  https://dx.doi.org/10.1002%2F14651858.CD007893.pub2
  10. Lin, Hsiao-Yi; Rocher, Leslie L.; McQuillan, Mark A.; Schmaltz, Stephan; Palella, Thomas D.; Fox, Irving H. (February 1990). "Cyclosporine-induced hyperuricemia and gout". The New England Journal of Medicine 322 (5): 334–6. doi:10.1056/NEJM199002013220514. PMID 2296276.  https://dx.doi.org/10.1056%2FNEJM199002013220514
  11. Agents Classified by the IARC Monographs, Volumes 1–110 http://monographs.iarc.fr/ENG/Classification/ClassificationsGroupOrder.pdf
  12. Humans, IARC Working Group on the Evaluation of Carcinogenic Risk to (2012) (in en). Ciclosporin. International Agency for Research on Cancer. https://www.ncbi.nlm.nih.gov/books/NBK304321/. 
  13. "Mechanisms of action of cyclosporine". Immunopharmacology 47 (2–3): 119–25. May 2000. doi:10.1016/S0162-3109(00)00192-2. PMID 10878286. http://web.khu.ac.kr/~biochem/source1.pdf. Retrieved 4 March 2018. 
  14. Ganong, William F. (2005). "27". Review of medical physiology (22nd ed.). New York: McGraw-Hill Medical. p. 530. ISBN 978-0-07-144040-0. https://archive.org/details/reviewmedicalphy00gano_326. 
  15. "Cardiac disease due to random mitochondrial DNA mutations is prevented by cyclosporin A". Biochemical and Biophysical Research Communications 319 (4): 1210–5. July 2004. doi:10.1016/j.bbrc.2004.05.104. PMID 15194495.  https://dx.doi.org/10.1016%2Fj.bbrc.2004.05.104
  16. "Effects of the calcineurin dependent signaling pathway inhibition by cyclosporin A on early and late cardiac remodeling following myocardial infarction". European Journal of Heart Failure 4 (6): 713–8. December 2002. doi:10.1016/S1388-9842(02)00120-4. PMID 12453541.  https://dx.doi.org/10.1016%2FS1388-9842%2802%2900120-4
  17. "Cyclophilin: a specific cytosolic binding protein for cyclosporin A". Science 226 (4674): 544–7. November 1984. doi:10.1126/science.6238408. PMID 6238408. Bibcode: 1984Sci...226..544H.  https://dx.doi.org/10.1126%2Fscience.6238408
  18. "Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice". Journal of Clinical Investigation 120 (10): 3680–7. October 2010. doi:10.1172/JCI43171. PMID 20890047.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2947235
  19. "Mitochondrial Permeability Transition: A Molecular Lesion with Multiple Drug Targets". Trends in Pharmacological Sciences 40 (1): 50–70. January 2019. doi:10.1016/j.tips.2018.11.004. PMID 30527591. https://discovery.ucl.ac.uk/id/eprint/10065055/1/TiPS%20manuscript%20accepted.pdf. 
  20. "Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury". Journal of Molecular and Cellular Cardiology 78: 142–53. January 2015. doi:10.1016/j.yjmcc.2014.08.015. PMID 25172387.  https://dx.doi.org/10.1016%2Fj.yjmcc.2014.08.015
  21. "Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release". Physiological Reviews 94 (3): 909–50. July 2014. doi:10.1152/physrev.00026.2013. PMID 24987008.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4101632
  22. "History of the discovery of cyclosporin and of its early pharmacological development". Wiener Klinische Wochenschrift 114 (12): 433–7. June 2002. PMID 12422576. Some sources list the fungus under an alternative species name Hypocladium inflatum gams such as Pritchard and Sneader in 2005:* "Sourcing a chemical succession for cyclosporin from parasites and human pathogens". Drug Discovery Today 10 (10): 688–91. May 2005. doi:10.1016/S1359-6446(05)03395-7. PMID 15896681.  * Sneader, Walter (23 June 2005). "Ciclosporin". Drug Discovery — A History. John Wiley & Sons. pp. 298–299. ISBN 978-0-471-89979-2. https://archive.org/details/drugdiscoveryhis00snea.  However, the name, "Beauveria nivea", also appears in several other articles including in a 2001 online publication by Harriet Upton entitled "Origin of drugs in current use: the cyclosporin story " (retrieved 19 June 2005). Mark Plotkin states in his book Medicine Quest, Penguin Books 2001, pages 46-47, that in 1996 mycology researcher Kathie Hodge found that it is in fact a species of Cordyceps.
  23. "Isolation of 10 cyclosporine metabolites from human bile". Drug Metabolism and Disposition 17 (3): 292–6. 1989. PMID 2568911.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3154783
  24. "Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectroscopy and nuclear magnetic resonance". Clinical Chemistry 36 (2): 225–9. February 1990. doi:10.1093/clinchem/36.2.225. PMID 2137384.  https://dx.doi.org/10.1093%2Fclinchem%2F36.2.225
  25. "Biosynthesis of cyclosporins and other natural peptidyl prolyl cis/trans isomerase inhibitors". Biochimica et Biophysica Acta (BBA) - General Subjects 1850 (10): 2111–20. October 2015. doi:10.1016/j.bbagen.2014.12.009. PMID 25497210.  https://dx.doi.org/10.1016%2Fj.bbagen.2014.12.009
  26. "Mechanism of cyclosporin A biosynthesis. Evidence for synthesis via a single linear undecapeptide precursor". Journal of Biological Chemistry 269 (4): 2841–6. January 1994. doi:10.1016/S0021-9258(17)42019-9. PMID 8300618.  https://dx.doi.org/10.1016%2FS0021-9258%2817%2942019-9
  27. "Structure and localization of cyclosporin synthetase, the key enzyme of cyclosporin biosynthesis in Tolypocladium inflatum". Archives of Microbiology 176 (4): 285–93. October 2001. doi:10.1007/s002030100324. PMID 11685373. http://link.springer.de/link/service/journals/00203/papers/1176004/11760285.pdf. 
  28. Dewick, P. (2001) Medicinal Natural Products. John Wiley & Sons, Ltd. 2nd ed.
  29. "Tolypocladium inflatum Benefits Fungal Adaptation to the Environment". mBio 9 (5). October 2018. doi:10.1128/mBio.01211-18. PMID 30279281.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=6168864
  30. "The genome of tolypocladium inflatum: evolution, organization, and expression of the cyclosporin biosynthetic gene cluster". PLOS Genetics 9 (6): e1003496. June 2013. doi:10.1371/journal.pgen.1003496. PMID 23818858.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3688495
  31. "Identification of cyclosporin C from Amphichorda felina using a Cryptococcus neoformans differential temperature sensitivity assay". Applied Microbiology and Biotechnology 102 (5): 2337–2350. March 2018. doi:10.1007/s00253-018-8792-0. PMID 29396588.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5942556
  32. "Alanine racemase from Tolypocladium inflatum: a key PLP-dependent enzyme in cyclosporin biosynthesis and a model of catalytic promiscuity". Archives of Biochemistry and Biophysics 529 (2): 55–65. January 2013. doi:10.1016/j.abb.2012.11.011. PMID 23219598.  https://dx.doi.org/10.1016%2Fj.abb.2012.11.011
  33. "The history of the discovery and development of Cyclosporin (Sandimmune)". The search for anti-inflammatory drugs case histories from concept to clinic. Boston: Birkhäuser. 1995. pp. 27–63. ISBN 978-1-4615-9846-6. https://books.google.com/books?id=YWXlBwAAQBAJ&pg=PA27. 
  34. Cheng, Myra (2013). "Hartmann Stahelin (1925-2011) and the contested history of cyclosporin A". Clinical Transplantation 27 (3): 326–329. doi:10.1111/ctr.12072. PMID 23331048.  https://dx.doi.org/10.1111%2Fctr.12072
  35. "Biological effects of cyclosporin A: a new antilymphocytic agent". Agents and Actions 6 (4): 468–75. July 1976. doi:10.1007/bf01973261. PMID 8969.  https://dx.doi.org/10.1007%2Fbf01973261
  36. "[Cyclosporin A, a Peptide Metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity]" (in de). Helvetica Chimica Acta 59 (4): 1075–92. 1976. doi:10.1002/hlca.19760590412. PMID 950308.  https://dx.doi.org/10.1002%2Fhlca.19760590412
  37. "The controversial early history of cyclosporin". Swiss Medical Weekly 131 (21–22): 299–302. June 2001. PMID 11584691. https://smw.ch/en/?type=7479858270737669&tx_ezmjournal_file%5Bresource%5D=smw.2001.09702.pdf&tx_ezmjournal_file%5Bidentifier%5D=smw.2001.09702&tx_ezmjournal_file%5Btype%5D=article&tx_ezmjournal_file%5Baction%5D=view&tx_ezmjournal_file%5Bcontroller%5D=File. Retrieved 10 January 2019. 
  38. "Cyclosporin A in patients receiving renal allografts from cadaver donors". The Lancet 2 (8104–5): 1323–7. 1978. doi:10.1016/S0140-6736(78)91970-0. PMID 82836.  https://dx.doi.org/10.1016%2FS0140-6736%2878%2991970-0
  39. "Liver transplantation with use of cyclosporin a and prednisone". The New England Journal of Medicine 305 (5): 266–9. July 1981. doi:10.1056/NEJM198107303050507. PMID 7017414.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2772056
  40. "FDA speeds approval of cyclosporin". Science 221 (4617): 1273. September 1983. doi:10.1126/science.221.4617.1273-a. PMID 17776314. Bibcode: 1983Sci...221.1273K. "On 2 September (1983), the Food and Drug Administration approved cyclosporin, a new drug that suppresses the immune system.".  https://dx.doi.org/10.1126%2Fscience.221.4617.1273-a
  41. Gottesman, Jill (20 March 1988). "Milestones in Cardiac Care". Los Angeles Times. http://articles.latimes.com/1988-03-20/magazine/tm-1895_1_cardiac-care. 
  42. "First Successful Pediatric Heart Transplant [9 June 1984"]. Columbia University Medical Center, Dept. of Surgery, Cardiac Transplant Program. http://columbiasurgery.org/news/2015/06/08/history-medicine-first-pediatric-heart-transplant. "It [cyclosporine] gained FDA approval at the end of 1983, ..." 
  43. "Drugs@FDA: FDA Approved Drug Products [Click on "Approval Date(s) and History"]. United States Food and Drug Administration. http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=050573. "Drug Name(s): Sandimmune (Cyclosporine), Company: Novartis, Action Date: 11/14/1983, Action Type: Approval, Submission Classification: Type 1 - New Molecular Entity, Review Priority: Priority" 
  44. "Guidelines on the Use of International Nonproprietary Names (INNs) for Pharmaceutical Substances". World Health Organization. 1997. http://apps.who.int/medicinedocs/en/d/Jh1806e/8.htm. "To facilitate the translation and pronunciation of INN, "f" should be used instead of "ph", "t" instead of "th", "e" instead of "ae" or "oe", and "i" instead of "y"; the use of the letters "h" and "k" should be avoided." 
  45. "Microemulsions for oral administration and their therapeutic applications". Expert Opinion on Drug Delivery 9 (8): 937–51. August 2012. doi:10.1517/17425247.2012.694865. PMID 22663249. https://hal.archives-ouvertes.fr/hal-00706176/document. 
  46. "Ikervis". Santen. http://www.santen.com/en/therapeutic-areas/asia/dryeye/ikervis/. 
  47. Clinical trial number NCT01287078 for "Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans" at ClinicalTrials.gov. https://www.clinicaltrials.gov/show/NCT01287078
  48. "Comparative permeability and diffusion kinetics of cyclosporine A liposomes and propylene glycol solution from human lung tissue into human blood ex vivo". European Journal of Pharmaceutics and Biopharmaceutics 70 (3): 758–64. November 2008. doi:10.1016/j.ejpb.2008.07.001. PMID 18656538.  https://dx.doi.org/10.1016%2Fj.ejpb.2008.07.001
  49. Administrator. "Hem - NeuroVive Pharmaceutical AB". neurovive.com. http://www.neurovive.com. 
  50. "Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor EL". Clinical Drug Investigation 33 (1): 25–34. January 2013. doi:10.1007/s40261-012-0029-x. PMID 23179472. PMC 3586182. http://lup.lub.lu.se/search/ws/files/2207190/3737528.pdf. 
  51. "Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury". Experimental Neurology 161 (2): 631–7. February 2000. doi:10.1006/exnr.1999.7282. PMID 10686082.  https://dx.doi.org/10.1006%2Fexnr.1999.7282
  52. "Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat". Acta Physiologica Scandinavica 155 (4): 469–71. December 1995. doi:10.1111/j.1748-1716.1995.tb09999.x. PMID 8719269.  https://dx.doi.org/10.1111%2Fj.1748-1716.1995.tb09999.x
  53. "Therapeutic window analysis of the neuroprotective effects of cyclosporine A after traumatic brain injury". Journal of Neurotrauma 28 (2): 311–8. February 2011. doi:10.1089/neu.2010.1646. PMID 21142667.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3037811
  54. "Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways". Proceedings of the National Academy of Sciences of the United States of America 95 (23): 13893–8. November 1998. doi:10.1073/pnas.95.23.13893. PMID 9811897. Bibcode: 1998PNAS...9513893M.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=24952
  55. "Increased cytochrome c correlates with poor survival in aggressive lymphoma". Oncology Letters 1 (2): 227–230. March 2010. doi:10.3892/ol_00000040. PMID 20798784.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2927837
  56. "Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition". Journal of Molecular and Cellular Cardiology 32 (4): 697–709. April 2000. doi:10.1006/jmcc.2000.1113. PMID 10756124.  https://dx.doi.org/10.1006%2Fjmcc.2000.1113
  57. "Oral cyclosporine treatment in dogs: a review of the literature". Journal of Veterinary Internal Medicine 28 (1): 1–20. 2014. doi:10.1111/jvim.12265. PMID 24341787.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4895546
  58. "Cyclosporine in veterinary dermatology". Veterinary Clinics of North America: Small Animal Practice 43 (1): 153–71. January 2013. doi:10.1016/j.cvsm.2012.09.007. PMID 23182330.  https://dx.doi.org/10.1016%2Fj.cvsm.2012.09.007
More
Upload a video for this entry
Information
Subjects: Others
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 2.4K
Entry Collection: HandWiki
Revision: 1 time (View History)
Update Date: 27 Oct 2022
Notice
You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
OK
Confirm
Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
Yes
No
${ textCharacter }/${ maxCharacter }
Submit
Cancel
There is no comment~
${ textCharacter }/${ maxCharacter }
Submit
Cancel
${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
Submit
Cancel
Confirm
Are you sure to Delete?
Yes No
Academic Video Service